Modern Slavery Act Policy
Modern Slavery Act Statement
Introduction
This statement is made pursuant to section 54(1) of the Modern Slavery Act 2015 and constitutes our slavery and human trafficking statement for the financial year ending 31st December 2025. This statement sets out the explicit steps EconoMed takes to proactively understand, identify, and eliminate any potential risk of modern slavery and human trafficking related to our commercial business operations and wider logistics networks.
Our Business & Supply Chain
EconoMed is a dedicated UK distributor of premium workplace equipment, administrative storage hardware, and facility maintenance consumables. We supply a focused range of industrial-grade assets and everyday commercial utility items to enterprises, workshops, corporate offices, and facility managers across the United Kingdom on a strictly centralised, 100% domestic stock model.
Our administrative headquarters are located in Warwick, Warwickshire, with physical fulfilment operations routed exclusively through our domestic logistics hub.
The primary sources of the inventory we distribute are established, highly regulated industrial manufacturers and commercial suppliers. The vast majority of our primary supply partners operate within territories where the statistical risk of modern slavery and human trafficking is verified as exceptionally low. Where we engage with global supply chains, robust validation controls and strict vendor onboarding protocols are firmly established.
Our Core Policy Commitment
EconoMed maintains an absolute, zero-tolerance opposition to modern slavery, forced labour, and human trafficking in every sector of our business, administrative footprint, and supply chain. We are unconditionally committed to implementing and enforcing effective operational procedures that identify, intercept, and prevent these unethical practices.
Our internal working practices and human resource frameworks commit EconoMed to providing a safe, transparent, and fair workplace environment that is entirely free from discrimination, intimidation, coercion, and exploitative conditions.
Risk Assessment & Supply Chain Due Diligence
Our corporate compliance framework requires regular risk profiling of the geographical regions and logistical networks where our manufacturing partners are situated. As part of our ongoing commitment to the Modern Slavery Act, EconoMed enforces the following due diligence steps:
• Supply Chain Profiling: Continually assessing potential exposure risk across our logistics lanes, prioritising closer scrutiny for components manufactured in high-risk zones.
• Vendor Mitigation: Actively reviewing the internal labour compliance protocols, ethical manufacturing certifications, and workforce standards maintained by our primary suppliers.
• Periodic Monitoring: Auditing our stock replenishment channels on a structured, recurring basis to guarantee ongoing alignment with UK statutory labour requirements.
If we identify a verified instance of modern slavery, severe exploitation, or a human trafficking infraction within a supply partner's operation, our management team will initiate immediate corrective measures. This action may include the instant suspension of trading accounts, permanent termination of the commercial relationship, and formal notification to the relevant legal authorities.
The executive responsibility for ensuring that our anti-slavery policies are strictly adhered to, regularly updated, and comprehensively enforced across all company activities rests directly with the senior leadership team of EconoMed.
Workforce Training & Operational Awareness
All personnel operating within our procurement, logistics, recruitment, and supply chain management teams undergo mandatory briefings regarding the statutory requirements of the Modern Slavery Act 2015. This training ensures our team remains fully equipped to identify warning signs of labour exploitation and report discrepancies immediately.
Monitoring & Status
EconoMed confirms there is zero risk of forced, involuntary, or child labour within our internal domestic corporate operation. We continue to work transparently with our supply partners to firmly reinforce our ethical standards.
This statement was formally approved and signed off by Fred Hopkinson, CEO, on 25th January 2026.